Design of sugar-oligonucleotide conjugates installed gold nanoparticle for effective delivery to hepatic parenchymal cells

Colloid and Polymer Science

Volumn 291, Issue 12, 2013, Pages 2959-2964

  Ikeda, Yutaka ^a   Kubota, Daisuke ^a   Nagasaki, Yukio ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

Author keywords

Carbohydrate; Gold nanoparticle; Oligonucleotide delivery; Receptor mediated process; Targeted delivery

Indexed keywords

CARBOHYDRATES; GOLD METALLOGRAPHY; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETRY; METAL NANOPARTICLES; OLIGONUCLEOTIDES; ORGANIC POLYMERS;

CARBOHYDRATE MODIFICATION; COMPETITION ASSAYS; FUNCTIONALIZED NANOPARTICLES; INDUCTIVELY COUPLED PLASMA MASS SPECTROSCOPIES; NANOPARTICLE CONJUGATE; OLIGONUCLEOTIDE CONJUGATES; PARENCHYMAL CELLS; TARGETED DELIVERY;

GOLD NANOPARTICLES;

CARBOHYDRATE; GALACTOSE; GLYCOCONJUGATE; GOLD NANOPARTICLE; LIGAND; OLIGONUCLEOTIDE; SUGAR;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CONJUGATE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; INCUBATION TIME; LIVER CELL; LIVER PARENCHYMA; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84892365165     PISSN: 0303402X     EISSN: 14351536     Source Type: Journal    
DOI: 10.1007/s00396-013-3029-3     Document Type: Article

References (27)

1. Que-Gewirth NS, Sullenger BA (2007) Gene therapy progress and prospects: RNA aptamers. Gene Ther 14:283-291
2. Castanotto D, Rossi JJ (2009) The promises and pitfalls of RNAinterference-based therapeutics. Nature 457:426-433
3. Nimesh S, Gupta N, Chandra R (2011) Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids. J Biomed Nanotechnol 7:504-520
4. Beyerle A, Hbel S, Czubayko F, Schulz H, Kissel T, Aigner A, Stoeger T (2009) In vitro cytotoxic and immunomodulatory profiling of low molecular weight polyethylenimines for pulmonary application. Toxicol in Vitro 23:500-508
5. Sundaram S, Lee LK, RothCM(2007) Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity. Nucleic Acid Res 35:4396-4408
6. Giljohann DA, Seferos DS, Daniel WL, Massich MD, Patel PC, Mirkin CA (2010) Gold nanoparticles for biology and medicine. Angew Chem Int Ed Engl 49:3280-3294
7. Zheng D, Giljohann DA, Chen DL, Massich MD, Wang XQ, Iordanov H, Mirkin CA, Paller AS (2012) Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci USA 109:11975-11980
8. Yang L, Zhang X, Ye M, Jiang J, Yang R, Fu T, Chen Y, Wang K, Liu C, Tan W (2011) Aptamer-conjugated nanomaterials and their applications. Adv Drug Deliv Rev 63:1361-1370
9. Yehl K, Joshi JP, Greene BL, Dyer RB, Nahta R, Salaita K (2012) Catalytic deoxyribozyme-modified nanoparticles for RNAiindependent gene regulation. ACS Nano 6:9150-9157
10. WeiM, Chen N, Li J, YinM, Liang L, He Y, Song H, Fan C, Huang Q (2012) Polyvalent immunostimulatory nanoagents with selfassembled CpG oligonucleotide-conjugated gold nanoparticles. Angew Chem Int Ed Engl 51:1202-1206
11. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA (2006) Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 312:1027-1030
12. Tamura M, Ichinohe S, Tamura A, Ikeda Y, Nagasaki Y (2011) In vitro and in vivo characteristics of core-shell type nanogel particles: optimization of core cross-linking density and surface poly(ethylene glycol) density in PEGylated nanogels. Acta Biomater 7:3354-3361
13. Hartmann H, Hossfeld S, Schlosshauer B, Mittnacht U, Pêgo AP, Dauner M, Doser M, Stoll D, Krastev R (2013) Hyaluronic acid/ chitosan multilayer coatings on neuronal implants for localized delivery of siRNA nanoplexes. J Control Release. doi:10.1016/j. jconrel.2013.03.026
14. Zhang K, Hao L, Hurst SJ, Mirkin CA (2012) Antibody-linked spherical nucleic acids for cellular targeting. J Am Chem Soc 134:16488-16491
15. Shukla RK, Tiwari A (2011) Carbohydrate molecules: an expanding horizon in drug delivery and biomedicine. Crit Rev Ther Drug Carrier Syst 28:255-292
16. Vasta GR (2009) Roles of galectins in infection. Nat Rev Microbiol 7:424-438
17. Ikeda Y, Kubota D, Nagasaki Y (2010) Simple solid-phase synthesis and biological properties of carbohydrate-oligonucleotide conjugates modified at the 3'-terminus. Bioconjug Chem 21:1685-1690
18. Ikeda Y, Jomura T, Horiuchi U, Saeki J, Yoshimoto K, Ikeya T, Nagasaki Y (2012) Long-term survival and functional maintenance of hepatocytes by using a microfabricated cell array. Colloids Surf B Biointerfaces 97:97-100
19. Yan H, Tram K (2007) Glycotargeting to improve cellular delivery efficiency of nucleic acids. Glycoconj J 24:107-123
20. Oishi M, Nagasaki Y, Itaka K, Nishiyama N, Kataoka K (2005) Lactosylated poly(ethylene glycol)-siRNA conjugate through acidlabile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells. J Am Chem Soc 127:1624-1625
21. Hurst SJ, Lytton-Jean AK,Mirkin CA(2006) MaximizingDNAloading on a range of gold nanoparticle sizes. Anal Chem 78:8313-8318
22. Giljohann DA, Seferos DS, Patel PC, Millstone JE, Rosi NL, Mirkin CA (2007) Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett 7:3818-3821
23. de la Fuente JM, Penadés S (2004) Understanding carbohydrate-carbohydrate interactions by means of glyconanotechnology. Glycoconj J 21:149-163
24. Rojo J, Díaz V, de la Fuente JM, Segura I, Barrientos AG, Riese HH, Bernad A, Penadés S (2004) Gold glyconanoparticles as new tools in antiadhesive therapy. ChemBioChem 5:291-297
25. Schwartz AL (1984) The hepatic asialoglycoprotein receptor. CRC Crit Rev Biochem 16:207-233
26. Hacker HJ, Thorens B, Grobholz R (1991) Expression of facilitative glucose transporter in rat liver and choroid plexus. A histochemical study in native cryostat sections. Histochemistry 96:435-439
27. Poelstra K, Prakash J, Beljaars L (2012) Drug targeting to the diseased liver. J Control Release 161:188-197